Research and Markets: Biomarkers Market 2015 - Global Forecast to 2020: Market is expected to reach $45.55 Billion by 2020 from $24.10 Billion in 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/v5v9qm/biomarkers_market) has announced the addition of the "Biomarkers Market by Product (Consumables, Services), Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine) & by Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020" report to their offering.

The global biomarkers market is expected to reach $45.55 Billion by 2020 from $24.10 Billion in 2015, at a CAGR of 13.58% between 2015 and 2020.

Increasing healthcare expenditure & R&D spending and the increasing utility of biomarkers for diagnostics are expected to drive the market. Market growth will also be aided by the low cost of clinical trials in developing countries and new initiatives undertaken for biomarker research. On the other hand, the need for high capital investment, low benefit-cost ratio, poorly suited regulatory & reimbursement systems, and the high cost of tests and sample collection & storage are the major factors restraining the growth of this market.

This report segments the global market by product, type of biomarker, application, disease indication, and geography. The product segments included in this report are consumables, services, & software. Based on type, biomarkers are segmented into safety, efficacy, and validation biomarkers. The applications included in this report are diagnostics development, drug discovery & development, personalized medicine, disease risk assessment and other applications. The disease indication segments included in this report are cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases.

The geographic analysis reveals that North America will account for the largest share of the global biomarkers market in 2015. Growth in this market can be attributed to strong growth trends in pharmaceutical companies and CROs. The Asian regional segment is expected to register double-digit growth from 2015 to 2020 owing to the expansion of leading biomarker companies and increased R&D spending. R&D spending in Asia increased from $177 billion in 2003 to $329 billion in 2010, at a CAGR of 9.29%. The R&D spending in Asia accounted for 27.13% of the global R&D expenditure in 2010.

Scope of the Report

Global Biomarkers Market, by Product

- Consumables

- Services

- Software

Global Biomarkers Market, by Type

- Safety Biomarkers

- Efficacy Biomarkers

- - Pharmacodynamics Biomarkers

- - Predictive Biomarkers

- - Prognostic Biomarkers

- - Surrogate Biomarkers

- Validation Biomarkers

Global Biomarkers Market, by Application

- Diagnostics Development

- Drug Discovery & Development

- Personalized Medicine

- Disease Risk Assessment

- Other Applications

Global Biomarkers Market, by Disease Indications

- Cancer

- Cardiovascular Disorders

- Neurological Disorders

- Immunological Disorders

- Other Diseases

Companies Mentioned

- Bio-Rad Laboratories, Inc.

- EKF Diagnostics Holdings, Inc.

- ENZO Biochem, Inc.

- Merck & Co, Inc.

- Perkinelmer, Inc.

- Qiagen N.V.

- Biosims Technologies

- Cisbio Bioassays

- Meso Scale Diagnostics, LLC.

- Signosis, Inc.

- Singulex, Inc.

For more information visit http://www.researchandmarkets.com/research/v5v9qm/biomarkers_market

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics